| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 2001;71:205-209
© 2001 The Society of Thoracic Surgeons
a Stanford University School of Medicine, Stanford, USA
b Baxter Novacor Division, Oakland, California, USA
Address reprint requests to Dr Portner, Department of Cardiothoracic Surgery, Falk Research Center, Stanford University School of Medicine, Stanford, California 94305-5407
Presented at the Thirty-Sixth Annual Meeting of The Society of Thoracic Surgeons, Fort Lauderdale, FL, Jan 31–Feb 2, 2000.
Background. Cumulative experience with the Novacor wearable electric left ventricular assist system (LVAS) now exceeds 850 recipients. The pump inflow conduit (IFC) has been implicated in embolic complications.
Methods. Clinical outcomes were compared for two IFC designs in a retrospective, nonrandomized, multicenter study. The original IFC (woven, unsupported, crimped polyester: control group) and an alternative IFC (knitted, gelatin-sealed, integrally supported, uncrimped polyester: test group) were utilized upon availability in North American and European centers. Differences in cerebral embolism to 180 days postimplant were analyzed.
Results. Four hundred ninety patients implanted between August 1996 and August 1999, were studied. Two hundred eighty-eight received the control IFC and 202 received the test IFC. The groups (control, test) were well matched for age (48, 49 years), etiology (idiopathic 53%[152 of 288], 55% [112 of 202]; ischemic 34% [97 of 288], 33% [66 of 202]) and mean observation time (97, 91 days). The incidence of embolic cerebrovascular accidents (CVA) was 21% (60 of 288) in the control and 12% (24 of 202) in the test group (p = 0.010). Independent risk factors for embolic CVA were found to be preimplant acute myocardial infarction (odds ratio 4.3), age above 50 years (odds ratio 2.1), and ischemic etiology (odds ratio 1.7). There was no difference in survival between the groups (71% [205 of 288], 68% [137 of 202]).
Conclusions. The alternative (test) IFC has significantly reduced the incidence of embolic CVA. This improvement is likely due to increased resistance to deformation at implant, improved neointimal adhesion, and more favorable blood flow characteristics within the conduit.
This article has been cited by other articles:
|
|
 |
|
  R. John, F. Kamdar, K. Liao, M. Colvin-Adams, A. Boyle, and L. Joyce Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy. Ann. Thorac. Surg., October 1, 2008; 86(4): 1227 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Cleveland Jr., F. L. Grover, D. A. Fullerton, D. N. Campbell, M. B. Mitchell, J. Lindenfeld, E. E. Wolfel, B. D. Lowes, S. F. Shakar, A. Brieke, et al. Left ventricular assist device as bridge to transplantation does not adversely affect one-year heart transplantation survival J. Thorac. Cardiovasc. Surg., September 1, 2008; 136(3): 774 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Struber, K. Sander, J. Lahpor, H. Ahn, P.-Y. Litzler, S. G. Drakos, F. Musumeci, C. Schlensak, I. Friedrich, R. Gustafsson, et al. HeartMate II left ventricular assist device; early European experience Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 289 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Seibel, P. Berdat, C. Boillat, B. Wagner, Z. Zachariou, and U. Kessler Hemostasis Management in Pediatric Mechanical Circulatory Support Ann. Thorac. Surg., April 1, 2008; 85(4): 1453 - 1456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Aggarwal, F. Cheema, M. C. Oz, and Y. Naka Long-Term Mechanical Circulatory Support Card. Surg. Adult, January 1, 2008; 3(2008): 1609 - 1628. [Full Text]
|
|
|
|
 |
|
 L. W. Miller, F. D. Pagani, S. D. Russell, R. John, A. J. Boyle, K. D. Aaronson, J. V. Conte, Y. Naka, D. Mancini, R. M. Delgado, et al. Use of a Continuous-Flow Device in Patients Awaiting Heart Transplantation N. Engl. J. Med., August 30, 2007; 357(9): 885 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. G. Rogers, J. Butler, S. L. Lansman, A. Gass, P. M. Portner, M. K. Pasque, R. N. Pierson III, and for the INTrEPID Investigators Chronic Mechanical Circulatory Support for Inotrope-Dependent Heart Failure Patients Who Are Not Transplant Candidates: Results of the INTrEPID Trial J. Am. Coll. Cardiol., August 21, 2007; 50(8): 741 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Tsukui, A. Abla, J. J. Teuteberg, D. M. McNamara, M. A. Mathier, L. M. Cadaret, and R. L. Kormos Cerebrovascular accidents in patients with a ventricular assist device J. Thorac. Cardiovasc. Surg., July 1, 2007; 134(1): 114 - 123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Butler, C. Geisberg, R. Howser, P. M. Portner, J. G. Rogers, M. C. Deng, and R. N. Pierson III Relationship between renal function and left ventricular assist device use. Ann. Thorac. Surg., May 1, 2006; 81(5): 1745 - 1751. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. El-Magharbel Ventricular Assist Devices and Anesthesia Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2005; 9(3): 241 - 249. [Abstract] [PDF]
|
|
|
|
|
|
K. Doi, L. A. R. Golding, A. L. Massiello, M. W. Kopcak Jr, R. L. Gerhart, S. Schenk, M. Inoue, Y. Ootaki, and K. Fukamachi Preclinical readiness testing of the arrow international CorAide left ventricular assist system Ann. Thorac. Surg., June 1, 2004; 77(6): 2103 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Morgan, R. John, V. Rao, A. D. Weinberg, B. J. Lee, P. A. Mazzeo, M. R. Flannery, J. M. Chen, M. C. Oz, and Y. Naka Bridging to transplant with the HeartMate left ventricular assist device: The Columbia Presbyterian 12-year experience J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1309 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. V. Letsou, T. J. Myers, I. D. Gregoric, R. Delgado, N. Shah, K. Robertson, B. Radovancevic, and O. H. Frazier Continuous axial-flow left ventricular assist device (Jarvik 2000) maintains kidney and liver perfusion for up to 6 months Ann. Thorac. Surg., October 1, 2003; 76(4): 1167 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. E. Richenbacher, Y. Naka, E. P. Raines, O. H. Frazier, G. S. Couper, F. D. Pagani, L. Damme, C. H. VanMeter, G. J. Magovern Jr, L. Gupta, et al. Surgical management of patients in the REMATCH trial Ann. Thorac. Surg., June 1, 2003; 75(90060): S86 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kono, K. Nishimura, T. Nishina, S. Yuasa, K. Ueyama, C. Hamada, T. Akamatsu, and M. Komeda Autosynchronized systolic unloading during left ventricular assist with a centrifugal pump J. Thorac. Cardiovasc. Surg., February 1, 2003; 125(2): 353 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Pasque and J. G. Rogers Adverse events in the use of HeartMate vented electric and Novacor left ventricular assist devices: Comparing apples and oranges J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1063 - 1067. [Full Text]
|
|
|
|
|
|
R. C. Robbins, M. H. Kown, P. M. Portner, and P. E. Oyer The totally implantable Novacor Left Ventricular Assist System Ann. Thorac. Surg., March 1, 2001; 71 (2007): S162 - S165. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
